XML 116 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Major Products (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Revenue from External Customer [Line Items]                      
Revenue, net $ 50,943 $ 50,004 $ 52,189 $ 53,224 $ 54,777 $ 51,570 $ 59,007 $ 54,827 $ 206,360 $ 220,181 $ 232,915
Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 100.00% 100.00% 100.00%
Protandim® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 135,616 $ 150,272 $ 156,335
Protandim® product line | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 65.70% 68.20% 67.10%
TrueScience® product line                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 22,877 $ 22,617 $ 23,739
TrueScience® product line | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 11.10% 10.30% 10.20%
Other                      
Revenue from External Customer [Line Items]                      
Revenue, net                 $ 47,867 $ 47,292 $ 52,841
Other | Product concentration risk | Revenue benchmark                      
Revenue from External Customer [Line Items]                      
Concentration risk                 23.20% 21.50% 22.70%